| 4IPF: reference: MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models., Tovar C, Graves B, Packman K, Filipovic Z, Higgins B, Xia M, Tardell C, Garrido R, Lee E, Kolinsky K, To KH, Linn M, Podlaski F, Wovkulich P, Vu B, Vassilev LT, Cancer Res. 2013 Feb 11. PMID: 23400593 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).